Crédit Mutuel, a private equity firm, and CapHorn, independent venture capital firm, led a €15m Series B funding round in Therapixel, a developer of a medical imaging technology, with participation from Verve, Sham Innovation Santé, Omnes, IT-Translation, M-Capital and Région Sud Investissement. “We are very happy with the closing of this fundraising with investors active in the field of digital health. These funds will allow our American team to grow and to ramp up their activities to deliver an already well filed pipeline. We are now recruiting sales and support people to supplement our experienced team," Matthieu Leclerc-Chalvet, Therapixel CEO.